Cargando…

Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis

Background: There are multiple glucose-lowering drugs available as alternative initial monotherapy for type 2 diabetes patients with contraindications or intolerance to metformin. However, little comparative and systematic data are available for them as initial monotherapy. This study estimated and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Shuyan, Hu, Xiaoqian, Shi, Lizheng, Zhen, Xuemei, Sun, Xueshan, Huang, Minzhuo, Gu, Yuxuan, Dong, Hengjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740076/ https://www.ncbi.nlm.nih.gov/pubmed/36498669 http://dx.doi.org/10.3390/jcm11237094

Ejemplares similares

Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2022)

Measurement and analysis of equity in health: a case study conducted in Zhejiang Province, China
por: Sun, Xueshan, et al.
Publicado: (2018)

Potential gains in health-adjusted life expectancy from reducing four main non-communicable diseases among Chinese elderly
por: Hu, Xiaoqian, et al.
Publicado: (2019)

Outpatient health-seeking behavior of residents in Zhejiang and Qinghai Province, China
por: Huang, Minzhuo, et al.
Publicado: (2019)

A comparative study of catastrophic health expenditure in Zhejiang and Qinghai province, China
por: Zhen, Xuemei, et al.
Publicado: (2018)

Social Determinants of Health-Related Quality of Life among Residents in Zhejiang and Qinghai, China
por: Gu, Yuxuan, et al.
Publicado: (2019)

Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis
por: Gu, Shuyan, et al.
Publicado: (2020)

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2015)

Trends in Cognitive Function Among Chinese Elderly From 1998 to 2018: An Age-Period-Cohort Analysis
por: Hu, Xiaoqian, et al.
Publicado: (2021)

Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis
por: Hu, Xiaoqian, et al.
Publicado: (2022)

Chinese Minority Perceives the Doctor-Patient Relationship Differently: A Cultural and Economic Interpretation
por: Yang, Qian, et al.
Publicado: (2019)

Osteoarthritis in the Middle-Aged and Elderly in China: Prevalence and Influencing Factors
por: Sun, Xueshan, et al.
Publicado: (2019)

Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
por: Sun, Xueshan, et al.
Publicado: (2021)

Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

The Quality of Caregivers for the Elderly in Long-Term Care Institutions in Zhejiang Province, China
por: Zeng, Yuhang, et al.
Publicado: (2019)

Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Modeling the Cost-effectiveness of Esophageal Cancer Screening in China
por: Li, Yuanyuan, et al.
Publicado: (2020)

Economic burden of antibiotic resistance in China: a national level estimate for inpatients
por: Zhen, Xuemei, et al.
Publicado: (2021)

Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients
por: Zhen, Xuemei, et al.
Publicado: (2021)

Cognitive and physical function of people older than 80 years in China from 1998 to 2014
por: Hu, Xiaoqian, et al.
Publicado: (2018)

Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
por: Zhen, Xuemei, et al.
Publicado: (2019)

The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis
por: Zhen, Xuemei, et al.
Publicado: (2019)

Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Effects of exercise and metformin on the prevention of glucose intolerance: a comparative study
por: Molena-Fernandes, C., et al.
Publicado: (2015)

The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study
por: Li, Yuanyuan, et al.
Publicado: (2022)

Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China
por: Gu, Shuyan, et al.
Publicado: (2016)

Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue
por: Biondo, Luana A., et al.
Publicado: (2018)

Pharmacokinetics of metformin in patients with gastrointestinal intolerance
por: McCreight, Laura J., et al.
Publicado: (2018)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
por: Irons, Brian K, et al.
Publicado: (2014)

Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice
por: Weiss, Roxanne, et al.
Publicado: (2018)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
Publicado: (2017)

Flos Lonicera Combined with Metformin Ameliorates Hepatosteatosis and Glucose Intolerance in Association with Gut Microbiota Modulation
por: Shin, Na R., et al.
Publicado: (2017)

Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments
por: Jiang, Shan, et al.
Publicado: (2022)

Secondary Failure of Metformin Monotherapy in Clinical Practice
por: Brown, Jonathan B., et al.
Publicado: (2010)

Metformin ameliorates olanzapine-induced obesity and glucose intolerance by regulating hypothalamic inflammation and microglial activation in female mice
por: Suh, Sang Bum, et al.
Publicado: (2022)

Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review
por: Weijenberg, Amerins, et al.
Publicado: (2015)

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019)

Efficacy and safety of different therapies of non-steroidal anti-inflammatory drugs against antibiotic monotherapy in the treatment of uncomplicated lower urinary tract infection: A systematic review
por: Gautam, Sandesh, et al.
Publicado: (2022)

Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab
por: Hata, Akito, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3l2ng9cmhvfv5vt1olp0nqpqej